OXIMIZE
DEAD

Serial Number

77781313

Owner

VEGAMIN CORPORATION

First Use Date

Jul 1, 2009

Filing Date

Jul 15, 2009

Add to watchlist:

No watchlists yet
View on USPTO

OXIMIZE Trademark

Serial Number: 77781313

OXIMIZE is a trademark filed by VEGAMIN CORPORATION on July 15, 2009. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

VEGAMIN CORPORATION (17 trademarks)

P.O. Box 570836
Tarzana, CA 91357

Entity Type: 03

Trademark Details

Filing Date

July 15, 2009

Registration Date

Not Registered

First Use Anywhere

July 1, 2009

First Use in Commerce

July 1, 2009

Published for Opposition

April 27, 2010

Goods & Services

Acne medications; Amino acids for nutritional purposes; Anti-cancer preparations; Anti-cavity dental coating preparations containing fluoride; Anti-infective products for veterinary use; Anti-microbial handwash; Antibacterial substances for medical purposes; Aromatized beverages based on fruit, protein, cordial, sugar and other fluid nutrients, namely, meal replacement drinks for use as a food fillers; Athletes' foot powders; Bacterial and bacteriological preparations for medical or veterinary purposes; Biochemical preparations for medical or veterinary purposes; Biscuits, bread, bread rolls, cakes, cereal products, confectionery, crackers, noodles, fish sauce, relish, sauces, cereal-based snack-foods and prepared dietary items all of which are gluten -free to accommodate special medical and health conditions; Calcium montmorillonite clay for therapeutic purposes used to enhance the production of enzymes in living beings or as a mineral supplement; Chewing gum for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Dietary and nutritional supplements; Dietary and nutritionally fortified food products adapted for medical use; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary pet supplements in the form of pet treats; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements for controlling cholesterol; Dietary supplements for pets in the nature of a powdered drink mix; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Energy boosting bars for use as a meal substitute; Face creams and cleansers containing benzoyl peroxide for medical purposes, namely, the treatment of acne; Food supplements, namely, anti-oxidants; Herbal supplements; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain; Liquid antipruritic; Liquid nutritional supplement; Meal replacement and dietary supplement drink mixes; Meal replacement bars; Medical cleansers for skin and wounds; Medicated chewing gum; Medicated cosmetics; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal creams for skin care; Mineral nutritional supplements; Multi-vitamin preparations; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Non-medicated additives for animal feed for use as nutritional supplements; Nutraceuticals for use as a dietary supplement; Nutritional drink mix for use as a meal replacement; Nutritional energy bars for use as a meal substitute; Nutritional meal replacement bars for individuals undergoing medical treatments; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the prevention and treatment of cancer; Powdered milk for babies; Powdered nutritional supplement drink mix; Pre-moistened medicated towelettes; Preparations for cleansing the skin for medical use; Protein supplements; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Topical analgesics; Veterinary preparations, namely, antioxidants; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Vitamin enriched water; Vitamin fortified beverages; Vitamin supplement in tablet form for use in making an effervescent beverage when added to water; Vitamins and dietary food supplements for animals

Filing History

ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
May 12, 2016 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
May 12, 2016 ABN4
OPPOSITION TERMINATED NO. 999999
May 12, 2016 OP.T
OPPOSITION SUSTAINED NO. 999999
May 12, 2016 OP.S
PETITION TO DIRECTOR DISMISSED
Apr 15, 2016 PC.D
ASSIGNED TO PETITION STAFF
Feb 1, 2016 APET
TEAS PETITION TO DIRECTOR RECEIVED
Jan 15, 2016 TPDR
ASSIGNED TO EXAMINER
Jun 30, 2014 DOCK
PETITION TO DIRECTOR DENIED
May 30, 2014 PCDE
ASSIGNED TO PETITION STAFF
May 5, 2014 APET
TEAS PETITION TO DIRECTOR RECEIVED
Mar 27, 2014 TPDR
REVIEW OF CORRESPONDENCE COMPLETE
Feb 2, 2012 CORV
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 7, 2011 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 5, 2011 TCCA
OPPOSITION INSTITUTED NO. 999999
Aug 25, 2010 OP.I
TEAS VOLUNTARY AMENDMENT RECEIVED
May 19, 2010 PARI
EXTENSION OF TIME TO OPPOSE RECEIVED
May 3, 2010 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 27, 2010 NPUB
PUBLISHED FOR OPPOSITION
Apr 27, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 24, 2010 PREV
ASSIGNED TO LIE
Mar 24, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 9, 2010 TROA
ASSIGNED TO EXAMINER
Jan 4, 2010 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 9, 2009 GNRN
NON-FINAL ACTION E-MAILED
Sep 9, 2009 GNRT
NON-FINAL ACTION WRITTEN
Sep 9, 2009 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2009 NWOS
NEW APPLICATION ENTERED
Jul 18, 2009 NWAP